Skip to main content
$5.90 -$0.15 (-2.5%)

10:34 AM EDT on 10/27/21

scpharmaceuticals (NASDAQ:SCPH)

CAPS Rating: No stars

Current Price $5.90 Mkt Cap $165.5M
Open $5.90 P/E Ratio 0.00
Prev. Close $6.05 Div. (Yield) $0.00 (0.0%)
Daily Range $5.90 - $5.90 Volume 877
52-Wk Range $4.75 - $9.64 Avg. Daily Vol. 33,433

Caps

How do you think NASDAQ:SCPH will perform against the market?

Add Stock to CAPS Watchlist

All Players

3 Outperform
5 Underperform
 

All-Star Players

0 Outperform
3 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:SCPH Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

odocoileus (61.44)
Submitted January 26, 2020

This is basically a bet on Furoscix. SCPH is billing this as an $8B market. Even if you turn the BS radar on, the potential is still dramatic compared to SCPH's market cap. If they manage to garner only $200-300M in sales they could be looking at a… More

TerryHogan (99.03)
Submitted October 31, 2018

The best thing you can say about this company is that it does have a decent amount of cash still to burn through. But the thing is, there's no short-term prospect of being cash-flow positive judging by the financials. There are dozens if not hundreds… More

NASDAQ:SCPH VS S&P 500 (SPY)

NASDAQ:SCPH Summary

Fools bullish on NASDAQ:SCPH are also bullish on:

Fools bearish on NASDAQ:SCPH are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about SCPH.

Recs

1
Member Avatar odocoileus (61.44) Submitted: 1/26/2020 1:47:36 AM : Outperform Start Price: $11.17 NASDAQ:SCPH Score: -119.47

This is basically a bet on Furoscix. SCPH is billing this as an $8B market. Even if you turn the BS radar on, the potential is still dramatic compared to SCPH's market cap. If they manage to garner only $200-300M in sales they could be looking at a $1B market cap. This seems easily doable. Even with almost certain dilution, the increase in share price would be significant. The question is, how likely are they to gain FDA approval? I got burned by green thumbing them before the last CRL. I believe they will make it through this next round. So if after your DD you believe they will make it through the FDA process, there are two ways to play this: Take a flyer and hope for a run up to approval, or pucker up and hold on for dear life. Either way, I think taking a flyer with money you can afford to lose could lead to some outsized gains. They are planning on having their submission complete by June. For a company that is a year or so away from a viable product, I think it is undervalued.

Recs

0
Member Avatar oscillation (75.33) Submitted: 2/22/2019 1:17:32 AM : Outperform Start Price: $3.23 NASDAQ:SCPH Score: +18.46

nev

Leaderboard

Find the members with the highest scoring picks in SCPH.

Score Leader

HDTVBG

HDTVBG (68.28) Score: +163.09

The Score Leader is the player with the highest score across all their picks in SCPH.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Smiley81 < 20 10/28/2019 Underperform 5Y $5.86 +0.68% +50.51% +49.83 0 Comment
liszewski 99.64 11/12/2018 Underperform 5Y $4.85 +21.65% +64.50% +42.85 0 Comment
johnnyrocku 99.80 11/12/2018 Underperform 5Y $4.85 +21.65% +64.50% +42.85 0 Comment
oscillation 75.33 2/22/2019 Outperform 5Y $3.23 +82.41% +63.95% +18.46 1 Comment
RayNobleEsq 99.93 11/27/2019 Underperform 5Y $4.26 +38.50% +44.62% +6.12 0 Comment
RTChokies 29.13 5/24/2019 Underperform 5Y $3.59 +64.35% +61.02% -3.32 0 Comment
Under5b < 20 6/9/2021 Outperform 5Y $5.80 +1.72% +7.90% -6.17 0 Comment
odocoileus 61.44 4/11/2018 3/30/2021 Outperform 3Y $11.17 -47.18% +72.29% -119.47 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for SCPH.